Just hitting the wires, these 5 health stocks that just received "Buy" ratings. These are very volatile stocks so please do your own research before you make any investments. While we may list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers.
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
Krystal Biotech, KRYS
Krystal Biotech (KRYS) has seen a 43.43% increase in price over the past month and a 47.09% increase in price over the past three months, and a 54.98% increase since the 6 month mark, leading to a market cap of $3.11B. Analysts are giving this stock a strong-buy consensus with a target price of $141.00, giving an upside of 22.12%. Volume has been high lately with an average 10 day volume of 566,193, and if the bullish analyst consensus continues, this stock is likely to continue to trend upwards.
- News Sentiment or KRYS stock: : Very Bullish
- Blogger Consensus or KRYS stock: : Bullish
- Media Buzz or KRYS stock: : Low
- Insider Signal or KRYS stock: : Negative
- Investor Sentiment or KRYS stock: : Very Positive
- Hedge Fund signal or KRYS stock: : Very Positive
Click for the KRYS stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
BridgeBio Pharma, BBIO
BridgeBio Pharma (BBIO) has seen an overall decrease of 5.30% in price over the last month, and an increase of 20.40% over the past three months, and an increase of 46.74% since the 6 month mark, giving it a market cap of $2.21B. Analysts are giving this stock a strong buy consensus and setting a target price of $29.57, giving an upside of 118.39%. Volume has been high lately with 1,317,725 average 10 day volume, and with the strong consensus of analysts this stock could continue to be bullish.
- News Sentiment or BBIO stock: : Very Bullish
- Blogger Consensus or BBIO stock: : Bullish
- Media Buzz or BBIO stock: : Very Low
- Insider Signal or BBIO stock: : ―
- Investor Sentiment or BBIO stock: : Positive
- Hedge Fund signal or BBIO stock: : Neutral
Click for the BBIO stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Geron, GERN
Geron (GERN) has an average volume of 5,372,493, with a one month gain of 32.11%, a three month gain of 16.91%, and a six month gain of 40.09%, leading to a market cap of $1.65B. Analysts have a strong buy consensus on this stock setting a target price of $5.00, giving it a realistic 50.60% upside. Volume has increased slightly lately and the positive analyst sentiment suggests that this stock could continue to trend upwards in the near future.
- News Sentiment or GERN stock: : Very Bullish
- Blogger Consensus or GERN stock: : Bullish
- Media Buzz or GERN stock: : Low
- Insider Signal or GERN stock: : ―
- Investor Sentiment or GERN stock: : Positive
- Hedge Fund signal or GERN stock: : Very Positive
Click for the GERN stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
iTeos Therapeutics, ITOS
iTeos Therapeutics (ITOS) has recently seen a decrease of 8.92% in price over the last day. The stock has seen a one month gain of 31.37%, a three month gain of 1.92%, and a six month loss of 10.42%, bringing it to a market cap of $645.54M. Analysts have returned a moderate buy consensus and have set a target price of $39.67, offering an impressive 141.30% upside. Volume has been low lately, but this could be offset by the bullish analyst consensus and the stock could continue to show potential gains in the future.
- News Sentiment or ITOS stock: : ―
- Blogger Consensus or ITOS stock: : Bullish
- Media Buzz or ITOS stock: : ―
- Insider Signal or ITOS stock: : Positive
- Investor Sentiment or ITOS stock: : Very Positive
- Hedge Fund signal or ITOS stock: : Neutral
Click for the ITOS stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
OptimizeRx, OPRX
OptimizeRx (OPRX) has a market cap of $243.38M and an average 10 day volume of 124,555. Over the past month, this stock has seen a negative 5.46% change in its price, a negative 20.39% change over the past three months, and negative 32.62% change since the 6 month mark. Analysts have given this stock a strong-buy consensus and set a target price of $21.50, offering investors an upside of 56.93%. With its low price target upside and the analysts consensus, this stock is likely to continue to trend downwards.
- News Sentiment or OPRX stock: : Very Bullish
- Blogger Consensus or OPRX stock: : Bullish
- Media Buzz or OPRX stock: : Low
- Insider Signal or OPRX stock: : ―
- Investor Sentiment or OPRX stock: : Very Positive
- Hedge Fund signal or OPRX stock: : Neutral
Click for the OPRX stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
